Table 2:
Initial symptoms and persistent symptoms at 90 days among patients diagnosed with COVID-19 in outpatient and inpatient settings
| Outpatients, no. (%); n = 326 | Inpatients, no. (%); n = 140 | |||
|---|---|---|---|---|
| Initial assessment | 90-day assessment | Initial assessment | 90-day assessment | |
| n (%) | n (%) | n (%) | n (%) | |
| Any symptom | 276 (84.7) | 74 (22.7) | 133 (95) | 59 (42.1) |
| Constitutional | 201 (61.7) | 38 (11.7) | 109 (77.9) | 34 (24.3) |
| Cardiorespiratory | 177 (54.3) | 27 (8.3) | 105 (75.0) | 29 (20.7) |
| Upper respiratory | 164 (50.3) | 10 (3.1) | 51 (36.4) | 11 (7.9) |
| Neurological | 189 (58.0) | 32 (9.8) | 73 (52.1) | 29 (20.7) |
| Gastrointestinal | 86 (26.4) | 3 (0.9) | 71 (50.7) | 5 (3.6) |
| Rheumatologic | 134 (41.1) | 28 (8.6) | 65 (46.4) | 33 (23.6) |
| Psychiatric | 92 (28.2) | 37 (11.4) | 63 (45.0) | 29 (20.7) |
| Fever | 101 (31.0) | 0 (0) | 76 (54.3) | 1 (0.7) |
| Pharyngitis | 95 (29.1) | 2 (0.6) | 22 (15.7) | 3 (2.1) |
| Rhinorrhea | 104 (31.9) | 6 (1.8) | 31 (22.1) | 6 (4.3) |
| Cough | 151 (46.3) | 13 (4.0) | 85 (60.7) | 7 (5.0) |
| Sputum | 24 (7.4) | 2 (0.6) | 25 (5.7) | 5 (3.6) |
| Hemoptysis | 1 (0.3) | 0 (0) | 3 (3.6) | 0 (0) |
| Dyspnea | 33 (10.1) | 10 (3.1) | 49 (35.0) | 16 (11.4) |
| Dyspnea at rest | 5 (1.5) | 2 (0.6) | 9 (6.4) | 3 (2.1) |
| Tachypnea | 9 (2.8) | 1 (0.3) | 12 (8.6) | 0 (0) |
| Breathless today | 11 (3.4) | 2 (0.6) | 12 (8.6) | 3 (2.1) |
| Chills | 76 (23.3) | 1 (0.3) | 44 (31.4) | 1 (0.7) |
| Chest pain | 43 (13.2) | 7 (2.2) | 28 (20.0) | 8 (5.7) |
| Wheezing | 7 (2.2) | 5 (1.5) | 8 (5.7) | 1 (0.7) |
| Otalgia | 15 (4.6) | 0 (0) | 7 (5.0) | 3 (2.1) |
| Conjunctivitis | 15 (4.6) | 4 (1.2) | 8 (5.7) | 0 (0) |
| Anosmia | 93 (28.5) | 18 (5.5) | 25 (17.9) | 10 (7.1) |
| Dysguesia | 107 (32.8) | 12 (3.7) | 22 (15.7) | 4 (2.9) |
| Myalgia | 123 (37.7) | 7 (2.2) | 62 (44.3) | 6 (4.3) |
| Arthralgia | 42 (12.9) | 5 (1.5) | 22 (15.7) | 7 (5.0) |
| Abdominal pain | 21 (6.4) | 3 (0.9) | 27 (19.3) | 2 (1.4) |
| Nausea/vomiting | 44 (13.5) | 0 (0) | 38 (27.1) | 2 (1.4) |
| Diarrhea | 46 (14.1) | 1 (0.3) | 39 (27.9) | 2 (1.4) |
| Lymphadenopathy | 4 (1.2) | 0 (0) | 0 (0) | 1 (0.7) |
| Rash | 6 (1.8) | 5 (1.5) | 2 (1.4) | 7 (5.0) |
| Fatigue | 165 (50.6) | 33 (10.1) | 88 (62.9) | 25 (17.9) |
| Headache | 134 (41.1) | 8 (2.5) | 55 (39.3) | 12 (8.6) |
| Confusion | 5 (1.5) | 17 (5.2) | 12 (8.6) | 14 (10.0) |
| Depression | 2 (0.6) | 12 (3.7) | 1 (0.7) | 9 (6.4) |
| Insomnia | 28 (8.6) | 17 (5.2) | 26 (18.6) | 17 (12.1) |
| Anorexia | 77 (23.6) | 2 (0.6) | 52 (37.1) | 5 (3.6) |
| Weight loss | - | 7 (2.2) | - | 14 (10.0) |
| Hair loss | - | 16 (4.9) | - | 22 (15.7) |